208 related articles for article (PubMed ID: 28065199)
1. Long-term effectiveness of plasma-derived hepatitis B vaccine 22-28 years after immunization in a hepatitis B virus endemic rural area: is an adult booster dose needed?
Li H; Li GJ; Chen QY; Fang ZL; Wang XY; Tan C; Yang QL; Wang FZ; Wang F; Zhang S; Bi SL; Shen LP
Epidemiol Infect; 2017 Apr; 145(5):887-894. PubMed ID: 28065199
[TBL] [Abstract][Full Text] [Related]
2. Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China.
Wang ZZ; Gao YH; Lu W; Jin CD; Zeng Y; Yan L; Ding F; Li T; Liu XE; Zhuang H
Hum Vaccin Immunother; 2017 Apr; 13(4):909-915. PubMed ID: 27874311
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of vaccinating infants with a 5 µg recombinant yeast-derived hepatitis B vaccine and the need for a booster dose in China.
Miao N; Zheng H; Sun X; Zhang G; Wang F
Sci Rep; 2020 Oct; 10(1):18155. PubMed ID: 33097788
[TBL] [Abstract][Full Text] [Related]
4. Long-term protection at 20-31 years after primary vaccination with plasma-derived hepatitis B vaccine in a Chinese rural community.
Ma JC; Wu ZW; Zhou HS; Gao Z; Hao ZY; Jin F; Zhang YH; Li MJ; Wang F; Li Q; Bi SL; Zhao YL
Hum Vaccin Immunother; 2020; 16(1):16-20. PubMed ID: 31339432
[No Abstract] [Full Text] [Related]
5. Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination.
Zhu CL; Liu P; Chen T; Ni Z; Lu LL; Huang F; Lu J; Sun Z; Qu C
Vaccine; 2011 Oct; 29(44):7835-41. PubMed ID: 21816197
[TBL] [Abstract][Full Text] [Related]
6. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
[TBL] [Abstract][Full Text] [Related]
7. Immune persistence 17 to 20 years after primary vaccination with recombination hepatitis B vaccine (CHO) and the effect of booster dose vaccination.
Zhao YL; Han BH; Zhang XJ; Pan LL; Zhou HS; Gao Z; Hao ZY; Wu ZW; Ma TL; Wang F; Li Q; Bi SL; Ma JC
BMC Infect Dis; 2019 May; 19(1):482. PubMed ID: 31146699
[TBL] [Abstract][Full Text] [Related]
8. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.
Samandari T; Fiore AE; Negus S; Williams JL; Kuhnert W; McMahon BJ; Bell BP
Pediatrics; 2007 Aug; 120(2):e373-81. PubMed ID: 17636112
[TBL] [Abstract][Full Text] [Related]
9. Implementation of hepatitis B vaccine in high-risk young adults with waning immunity.
Posuwan N; Vorayingyong A; Jaroonvanichkul V; Wasitthankasem R; Wanlapakorn N; Vongpunsawad S; Poovorawan Y
PLoS One; 2018; 13(8):e0202637. PubMed ID: 30125298
[TBL] [Abstract][Full Text] [Related]
10. The long-term efficacy, 13-23 years, of a plasma-derived hepatitis B vaccine in highly endemic areas in China.
Wang F; Shen L; Cui F; Zhang S; Zheng H; Zhang Y; Liang X; Wang F; Bi S
Vaccine; 2015 May; 33(23):2704-9. PubMed ID: 25843269
[TBL] [Abstract][Full Text] [Related]
11. Predictive factors for anti-HBs status after 1 booster dose of hepatitis B vaccine.
Lu IC; Jean MC; Lin CW; Chen WH; Perng DS; Lin CW; Chuang HY
Medicine (Baltimore); 2016 Sep; 95(39):e5023. PubMed ID: 27684874
[TBL] [Abstract][Full Text] [Related]
12. Persistence of hepatitis B surface antibody and immune memory to hepatitis B vaccine among medical college students in Madinah.
Mahallawi W
Ann Saudi Med; 2018; 38(6):413-419. PubMed ID: 30531175
[TBL] [Abstract][Full Text] [Related]
13. Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan.
Su FH; Bai CH; Chu FY; Lin YS; Su CT; Yeh CC
Vaccine; 2012 Jun; 30(27):4034-9. PubMed ID: 22531558
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of hepatitis B and immune response to hepatitis B vaccination in Chinese college students mainly from the rural areas of western China and born before HBV vaccination integrated into expanded program of immunization.
Liao XY; Zhou ZZ; Wei FB; Qin HN; Ling Y; Li RC; Li YP; Nong Y; Sun KX; Li J; Zhuang H
Hum Vaccin Immunother; 2014; 10(1):224-31. PubMed ID: 24018404
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of yeast-derived recombinant hepatitis B vaccine after being used for 12 years in highly endemic areas in China.
Shen L; Wang F; Wang F; Cui F; Zhang S; Zheng H; Zhang Y; Liang X; Bi S
Vaccine; 2012 Oct; 30(47):6623-7. PubMed ID: 22959987
[TBL] [Abstract][Full Text] [Related]
16. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness.
de la Hoz F; Perez L; de Neira M; Hall AJ
Int J Infect Dis; 2008 Mar; 12(2):183-9. PubMed ID: 17913535
[TBL] [Abstract][Full Text] [Related]
17. [Observation on effects of hepatitis B vaccine immunization for 12 years in children in Beijing].
Gong XH; Wang FZ; Li H; Liu LR; Li YH; Wang BL; Li LQ; Zhang Z; Han QY; Tang YW
Zhonghua Yu Fang Yi Xue Za Zhi; 2005 Jul; 39(4):265-8. PubMed ID: 16194384
[TBL] [Abstract][Full Text] [Related]
18. Post-vaccination serologic testing of infants born to hepatitis B surface antigen positive mothers in 4 provinces of China.
Wang F; Zhang G; Zheng H; Miao N; Shen L; Wang F; Dong P; Du F; Chen C; Zhang X; Cui F
Vaccine; 2017 Jul; 35(33):4229-4235. PubMed ID: 28651839
[TBL] [Abstract][Full Text] [Related]
19. Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine.
Zhang L; Gui XE; Teter C; Zhong H; Pang Z; Ding L; Li F; Zhou Y; Zhang L
Vaccine; 2014 Oct; 32(46):6091-7. PubMed ID: 25240752
[TBL] [Abstract][Full Text] [Related]
20. [Persistence of HB vaccine immune protection and response to hepatitis B booster immunization].
Li H; Li R; Liao S; Yang J; Zeng X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Feb; 20(1):54-9. PubMed ID: 11367735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]